![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SPATS2 |
Gene summary for SPATS2 |
![]() |
Gene information | Species | Human | Gene symbol | SPATS2 | Gene ID | 65244 |
Gene name | spermatogenesis associated serine rich 2 | |
Gene Alias | Nbla00526 | |
Cytomap | 12q13.12 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | A0A024R101 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
65244 | SPATS2 | P10T-E | Human | Esophagus | ESCC | 5.54e-24 | 5.37e-01 | 0.116 |
65244 | SPATS2 | P11T-E | Human | Esophagus | ESCC | 3.36e-11 | 7.49e-01 | 0.1426 |
65244 | SPATS2 | P12T-E | Human | Esophagus | ESCC | 4.43e-19 | 4.03e-01 | 0.1122 |
65244 | SPATS2 | P15T-E | Human | Esophagus | ESCC | 8.26e-24 | 4.60e-01 | 0.1149 |
65244 | SPATS2 | P16T-E | Human | Esophagus | ESCC | 1.06e-36 | 6.91e-01 | 0.1153 |
65244 | SPATS2 | P19T-E | Human | Esophagus | ESCC | 2.16e-04 | 6.24e-01 | 0.1662 |
65244 | SPATS2 | P20T-E | Human | Esophagus | ESCC | 6.64e-34 | 7.86e-01 | 0.1124 |
65244 | SPATS2 | P21T-E | Human | Esophagus | ESCC | 2.93e-25 | 5.38e-01 | 0.1617 |
65244 | SPATS2 | P22T-E | Human | Esophagus | ESCC | 3.08e-25 | 4.17e-01 | 0.1236 |
65244 | SPATS2 | P23T-E | Human | Esophagus | ESCC | 2.99e-18 | 5.34e-01 | 0.108 |
65244 | SPATS2 | P24T-E | Human | Esophagus | ESCC | 9.62e-27 | 4.73e-01 | 0.1287 |
65244 | SPATS2 | P26T-E | Human | Esophagus | ESCC | 1.16e-28 | 6.21e-01 | 0.1276 |
65244 | SPATS2 | P27T-E | Human | Esophagus | ESCC | 1.53e-33 | 6.93e-01 | 0.1055 |
65244 | SPATS2 | P28T-E | Human | Esophagus | ESCC | 6.85e-13 | 3.46e-01 | 0.1149 |
65244 | SPATS2 | P30T-E | Human | Esophagus | ESCC | 2.77e-25 | 8.95e-01 | 0.137 |
65244 | SPATS2 | P31T-E | Human | Esophagus | ESCC | 3.71e-50 | 9.74e-01 | 0.1251 |
65244 | SPATS2 | P32T-E | Human | Esophagus | ESCC | 2.85e-26 | 4.84e-01 | 0.1666 |
65244 | SPATS2 | P36T-E | Human | Esophagus | ESCC | 3.76e-20 | 5.64e-01 | 0.1187 |
65244 | SPATS2 | P37T-E | Human | Esophagus | ESCC | 3.69e-37 | 9.12e-01 | 0.1371 |
65244 | SPATS2 | P38T-E | Human | Esophagus | ESCC | 1.79e-13 | 6.02e-01 | 0.127 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SPATS2 | SNV | Missense_Mutation | rs781041192 | c.1265N>T | p.Pro422Leu | p.P422L | Q86XZ4 | protein_coding | deleterious(0.03) | benign(0.166) | TCGA-D8-A1Y3-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicine+cyclophosphamide | SD |
SPATS2 | SNV | Missense_Mutation | c.229G>T | p.Val77Leu | p.V77L | Q86XZ4 | protein_coding | deleterious(0.01) | probably_damaging(0.978) | TCGA-EW-A1PC-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | SD | |
SPATS2 | deletion | Frame_Shift_Del | novel | c.565delN | p.Lys189SerfsTer3 | p.K189Sfs*3 | Q86XZ4 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
SPATS2 | deletion | Frame_Shift_Del | novel | c.663delN | p.Met223TrpfsTer12 | p.M223Wfs*12 | Q86XZ4 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
SPATS2 | SNV | Missense_Mutation | c.371N>T | p.Ser124Leu | p.S124L | Q86XZ4 | protein_coding | tolerated(0.17) | benign(0.01) | TCGA-IR-A3LI-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
SPATS2 | SNV | Missense_Mutation | c.1480N>G | p.Gln494Glu | p.Q494E | Q86XZ4 | protein_coding | tolerated(0.09) | benign(0.107) | TCGA-IR-A3LI-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
SPATS2 | SNV | Missense_Mutation | rs769173005 | c.767N>A | p.Arg256Gln | p.R256Q | Q86XZ4 | protein_coding | deleterious(0.02) | benign(0.046) | TCGA-VS-A9V4-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
SPATS2 | SNV | Missense_Mutation | c.1423N>T | p.Arg475Cys | p.R475C | Q86XZ4 | protein_coding | deleterious(0.01) | possibly_damaging(0.609) | TCGA-A6-5661-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SPATS2 | SNV | Missense_Mutation | novel | c.263N>C | p.Lys88Thr | p.K88T | Q86XZ4 | protein_coding | deleterious(0.02) | probably_damaging(0.998) | TCGA-AA-3855-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SPATS2 | SNV | Missense_Mutation | c.314N>A | p.Gly105Asp | p.G105D | Q86XZ4 | protein_coding | tolerated(0.33) | benign(0.061) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |